MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH)

CUSIP: 57060U217

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / PHARMACEUTICAL
Total 13F shares
2,747,166
Share change
+1,284,814
Total reported value
$194,312,958
Price per share
$70.75
Number of holders
60
Value change
+$90,894,968
Number of buys
28
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 57060U217?
CUSIP 57060U217 identifies PPH - MARKET VECTORS ETF TR - PHARMACEUTICAL in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) as of Q2 2015

As of 30 Jun 2015, MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,747,166 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, MORGAN STANLEY, ENVESTNET ASSET MANAGEMENT INC, UNITED CAPITAL FINANCIAL ADVISERS, LLC, MACROVIEW INVESTMENT MANAGEMENT LLC, RAYMOND JAMES & ASSOCIATES, JANE STREET GROUP, LLC, HOKANSON ASSOCIATES, INC., Clal Insurance Enterprises Holdings Ltd, and HighTower Advisors, LLC. This page lists 60 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.